Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients
Nadia Rodríguez-Rodríguez(Centro de Ingeniería Genética y Biotecnología), Jorge Berlanga‐Acosta(Centro de Ingeniería Genética y Biotecnología), Ariana García‐Ojalvo(Centro de Ingeniería Genética y Biotecnología), Yssel Mendoza‐Marí(Western University of Health Sciences), Gerardo Guillén(Hunan City University), Indira Martínez-Jiménez(Centro de Ingeniería Genética y Biotecnología), David Armstrong(University of Southern California)
Cited by 139
Related Papers
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
|Annals of Oncology|1998|155
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing
|BioMed Research International|2012|153
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
|Frontiers in Endocrinology|2020|134
Domain III of the envelope protein as a dengue vaccine target
|Expert Review of Vaccines|2010|125